SPOTLIGHT: Erbitux gets first-line status

The cancer drug Erbitux can be marketed as a first-line treatment for colon cancer, now that the FDA has OK'd a label change. The drug is made and marketed by ImClone Systems and Bristol-Myers Squibb. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.